# GLP-1s

Type: Technology

Source: GetYourBrief — https://getyourbrief.com/entity/glp-1s
Canonical HTML page: https://getyourbrief.com/entity/glp-1s

## Timeline

- **2026-02-24**: Global Market Reaction — Industry analysts note the deal as a major consolidation in the GLP-1 and telehealth sectors.
- **2026-02-24**: Employee Windfall Reports — Detailed reports emerge regarding the 100+ employees reaching millionaire status in Sydney.
- **2026-02-23**: Payout Details Emerge — Former CCO Joe Harris confirms a payout exceeding $1 million, highlighting the impact on staff wealth.
- **2026-02-23**: Employee Windfall — Details of the $300M employee share pool emerge, confirming 100+ new millionaires.
- **2026-02-23**: Executive Payouts Confirmed — Former CCO Joe Harris confirms a $1M+ payout in an interview with the Australian Financial Review.
- **2026-02-19**: Acquisition Announced — Hims & Hers officially announces the $1.6 billion buyout of Sydney-based Eucalyptus.
- **2026-02-19**: Acquisition Announced — Hims & Hers officially announces the $1.6 billion deal to acquire Eucalyptus.
- **2026-02-19**: Acquisition Announced — Hims & Hers officially announces the $1.6 billion acquisition of Eucalyptus.
- **2024**: GLP-1 Surge — Juniper and Pilot brands see explosive growth driven by demand for weight-loss medications.
- **2019**: Eucalyptus Founded — Tim Doyle launches the company, inspired by the Hims & Hers telehealth model in the US.

## Recent coverage (6 stories, network-wide)

### GLP-1 Surge Powers Stevanato Growth as Pulmonx Navigates Sales Restructuring
2026-03-05 00:20:39 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 14

Stevanato Group reported a 50% surge in GLP-1 related revenue for 2025, underscoring the massive impact of the weight-loss drug market on pharmaceutical supply chains. Conversely, medical device maker Pulmonx is undergoing a significant transition following a 50% turnover in its sales organization and a dip in U.S. quarterly revenue.
Full story: https://getbiobrief.com/story/stevanato-pulmonx-q4-2025-earnings-analysis

### GLP-1 Surge Drives Stevanato Growth as MedTech Sector Pivots to Efficiency
2026-03-05 00:14:04 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 14

Stevanato Group reported robust 2025 results fueled by a 50% surge in GLP-1 related revenue, while medical device maker Pulmonx initiated aggressive cost-cutting measures following a U.S. revenue decline. The divergence highlights a shifting healthcare landscape where specialized biopharma supply chains are outperforming traditional niche medical devices.
Full story: https://gethealthbrief.com/story/stevanato-pulmonx-earnings-glp1-trends-2025

### Hims & Hers Acquires Eucalyptus for $1.6B in Landmark Telehealth Consolidation
2026-02-24 04:12:41 · Sector: saas · Sentiment: Positive · Impact: 7/10 · Sources: 2

US telehealth giant Hims & Hers has completed a $1.6 billion acquisition of Australian startup Eucalyptus, marking a massive expansion into the Asia-Pacific market. The deal has created over 100 millionaires among Eucalyptus's Sydney-based workforce through a $300 million employee share pool.
Full story: https://getsaasbrief.com/story/hims-and-hers-acquires-eucalyptus-1-6-billion-deal

### Hims & Hers Acquires Eucalyptus for $1.6B, Minting 100 Aussie Millionaires
2026-02-24 04:12:08 · Sector: startups · Sentiment: Positive · Impact: 7/10 · Sources: 2

US telehealth giant Hims & Hers has acquired Sydney-based startup Eucalyptus in a landmark $1.6 billion deal. The acquisition, fueled by a $637 million revenue run-rate and the global GLP-1 weight loss boom, has created over 100 overnight millionaires among the Australian firm's staff.
Full story: https://getstartupbrief.com/story/hims-and-hers-eucalyptus-acquisition-analysis

### Hims & Hers Acquires Eucalyptus for $1.6B in Global Telehealth Consolidation
2026-02-24 04:10:02 · Sector: health · Sentiment: Positive · Impact: 7/10 · Sources: 2

US telehealth leader Hims & Hers has finalized a $1.6 billion acquisition of Australian digital health startup Eucalyptus, marking a major expansion into the Asia-Pacific market. The deal, driven by the explosive growth of GLP-1 weight-loss treatments, creates over 100 employee millionaires and solidifies Hims & Hers' position as a global powerhouse in direct-to-consumer healthcare.
Full story: https://gethealthbrief.com/story/hims-hers-eucalyptus-acquisition-glp1-telehealth

### Hims & Hers Acquires Eucalyptus for $1.6B, Creating 100+ Employee Millionaires
2026-02-24 04:09:29 · Sector: hr · Sentiment: Positive · Impact: 7/10 · Sources: 2

US telehealth leader Hims & Hers has acquired Australian startup Eucalyptus in a $1.6 billion deal, triggering a massive wealth event for over 100 employees through its share option plan. The acquisition highlights the explosive growth of the GLP-1 and telehealth markets while setting a new benchmark for employee equity outcomes in the Australian tech ecosystem.
Full story: https://gethrbrief.com/story/hims-hers-eucalyptus-acquisition-employee-wealth

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.